Cor triatriatum

From WikiMD's WELLNESSPEDIA

(Redirected from Cor triatriatum sinistrum)


Cor triatriatum
Synonyms Triatrial heart
Pronounce N/A
Specialty N/A
Symptoms Shortness of breath, fatigue, palpitations, chest pain
Complications Heart failure, pulmonary hypertension, atrial fibrillation
Onset Congenital
Duration Lifelong
Types N/A
Causes Congenital heart defect
Risks Congenital heart disease
Diagnosis Echocardiography, MRI, CT scan
Differential diagnosis Atrial septal defect, mitral stenosis
Prevention N/A
Treatment Surgical resection, balloon atrial septostomy
Medication N/A
Prognosis Variable, depending on severity and treatment
Frequency Rare
Deaths N/A


Cor triatriatum is a rare congenital heart defect where the left atrium or the right atrium is divided into two parts by a fold of tissue, a membrane, or a fibromuscular band.

Overview[edit]

Cor triatriatum represents 0.1% of all congenital heart diseases. The condition can occur on its own or in association with other cardiac anomalies, such as atrial septal defect, ventricular septal defect, patent ductus arteriosus, and anomalous pulmonary venous connection.

Symptoms[edit]

The symptoms of cor triatriatum depend on the size of the opening in the fibromuscular membrane and whether other heart defects are present. Symptoms may include shortness of breath, fatigue, palpitations, and cyanosis.

Diagnosis[edit]

Cor triatriatum is typically diagnosed using echocardiography, which can visualize the abnormal membrane and assess its hemodynamic significance. Other diagnostic tests may include cardiac catheterization, computed tomography (CT) scan, and magnetic resonance imaging (MRI).

Treatment[edit]

The treatment for cor triatriatum is surgical removal of the abnormal membrane to restore normal blood flow. The prognosis after surgery is generally good, with most patients experiencing a significant improvement in symptoms and quality of life.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.